Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
21.14
+3.55 (20.18%)
At close: May 29, 2026, 4:00 PM EDT
20.88
-0.26 (-1.23%)
After-hours: May 29, 2026, 4:43 PM EDT
Sensei Biotherapeutics Market Cap
Sensei Biotherapeutics has a market cap or net worth of $28.37 million as of May 29, 2026. Its market cap has increased by 210.19% in one year.
Market Cap
28.37M
Enterprise Value
-174.94M
1-Year Change
210.19%
Ranking
Category
Stock Price
$21.14
Market Cap Chart
Since the IPO on February 4, 2021, Sensei Biotherapeutics's market cap has decreased from $561.61M to $28.37M, a decrease of -94.95%. That is a compound annual growth rate of -42.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 23.60M | 75.40% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.40% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyntra Bio | 28.54M |
| CervoMed | 28.24M |
| Serina Therapeutics | 28.01M |
| IGC Pharma | 27.99M |
| Palatin Technologies | 27.53M |
| Skye Bioscience | 27.38M |
| Barinthus Biotherapeutics | 27.07M |
| Dyadic International | 26.38M |